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DNA methylation-dependent gene silencing, mediated by DNA methyltransferases (DNMTs), is essential for normal mammalian development
and its dysregulation has been implicated in neurodevelopmental disorders. Despite this, little is known about DNMTs in the developing or mature
nervous system. Here, we show that DNMT1, 3a and 3b are expressed at discrete developmental stages in the olfactory neuron lineage, coincident
with key shifts in developmental gene expression. DNMT1 is induced in cycling progenitors and is retained in post-mitotic olfactory receptor
neurons (ORNs). DNMT3b is restricted to mitotic olfactory progenitors, whereas DNMT3a is expressed only in post-mitotic immature neurons
prior to ORN terminal maturation, coincident with histone deacetylase 2 (HDAC2), a key downstream effector of methylation-dependent
chromatin condensation. Similar stage-specific expression of DNMT3b and 3a was also found in other developing sensory and CNS neurons. This
suggests that progressive lineage restriction regulated by methylation-dependent silencing could be a highly conserved mechanism shared by
multiple lineages in the developing nervous system.
D 2005 Elsevier Inc. All rights reserved.Keywords: Epigenetics; Methyl binding domain proteins; Neuronal differentiation; Lineage restrictionIntroduction
Modification of mammalian DNA by cytosine methylation
can initiate epigenetic gene silencing (reviewed in (Bird, 2002)),
a process essential for mammalian development (Li, 2002;
Weiss and Cedar, 1997), imprinting (Li et al., 1993) (Razin and
Cedar, 1994) and X-chromosome inactivation (Razin and Cedar,
1991). Cytosine methylation can sterically hinder transcription
factors from binding to a promoter, or alternatively silence
stretches of chromatin, via the recruitment of histone deacetylase
(HDAC)-containing repressor complexes by Methyl Binding
Domain (MBD) proteins (reviewed in (Bird, 2002)). DNA
methylation patterns become mosaics in different cells and
tissues due to an ordered demethylation and re-methylation
process that occurs during development (Bestor et al., 1988;
Jaenisch and Bird, 2003; Okano et al., 1998a). To achieve this,
the de novo DNA methyltransferases (DNMT3a, 3b) target
unmethylated CpGs to establish new methylation patterns (Li et0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.09.048
* Corresponding author. Fax: +1 604 827 5085.
E-mail address: roskams@zoology.ubc.ca (A.J. Roskams).
1 Both authors contributed equally to this work.al., 1992; Okano et al., 1999), whereas DNMT1, a maintenance
methyltransferase, methylates hemi-methylated CpGs during
DNA replication (Pradhan et al., 1999; Yoder et al., 1997).
As development proceeds, the activation of cell lineage-
determining genes leads to establishment of cell-type-specific
gene expression. Genes involved in progressive lineage
restriction are tightly regulated so that expression of these
genes is prevented in an alternative lineage. Cell-type and
stage-specific DNA methylation could establish the expression
pattern of such determinative genes and contribute to the
stability or plasticity of a specific differentiation state (Jaenisch
and Bird, 2003). Abnormalities in DNA methylation have been
implicated in aberrant mitosis (Jones and Baylin, 2002),
developmental disorders (Hansen et al., 1999; Xu et al.,
1999) and polygenic neuropsychiatric disorders such as Autism
and Schizophrenia (Abdolmaleky et al., 2004; Jiang et al.,
2004). The nervous system appears particularly vulnerable to
changes in DNA methylation-dependent silencing, evidenced
by the widespread CNS effects in Rett Syndrome, a neurode-
velopmental disorder resulting from a mutation in the MBD,
Mecp2, and the leading cause of mental retardation in females
(Amir et al., 1999; Shahbazian et al., 2002). The absence of88 (2005) 461 – 473
www.e
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neural stem cell neurogenesis, (Zhao et al., 2003) and DNMT1
and MBDs are implicated in the differential vulnerability of
cortical neurons to resist death following ischemia or kindling
(Endres et al., 2000; Jung et al., 2002).
Vertebrate neurons are transcriptionally complex and must
traverse several discrete stages of differentiation and switches in
state in order to functionally mature. DNA methylation is an
ideal mechanism for translating extracellular stimuli into
chromatin-based gene silencing that can affect entire sets of
genes essential to complete one stage of development, but may
not be required again (Hsieh et al., 2004; Korzus et al., 2004).
Null mice for DNMT1 and 3b are embryonic lethal and exhibit
early nervous system deficits, with only DNMT3a nulls
exhibiting limited postnatal survival (Li et al., 1992; Okano et
al., 1999). The complexity of the embryonic nervous system—
where single regions contain a variety of neurons at different
developmental stages—is a highly challenging environment in
which to test how DNA methylation may affect the develop-
ment of a single neuronal lineage. Olfactory receptor neurons






Dnmt 3b exon 11 GCGTCAGTACCCCATCAGTT
Dnmt 3b exon 22/23 ACTTGGTGATTGGTGGAAGChowever, a highly accessible simple neuronal lineage in which
to examine the stage-specific roles of developmentally regulat-
ed processes, such as DNA methylation, on neurogenesis. The
OE is organized in a stratified, developmentally hierarchical
manner, allowing for the identification of developmentally
restricted gene expression patterns, and mature ORNs represent
a singular chemosensory neuronal phenotype, with only
minimal gene expression differences (other than their odorant
receptor) between them (Schwob, 2002). Because they undergo
complete functional regeneration throughout adulthood (Carr
and Farbman, 1992; Graziadei and Graziadei, 1979; Huard et
al., 1998), we can examine mechanisms of neuronal differen-
tiation, regeneration, and plasticity in ORNs, in exclusion of
other neurons. In order to test how DNAmethylation-dependent
silencing can affect ORN development, we must first discover
the identity and time windows of action of the key players—the
DNMTs that lay down the initial methylation marks (Bestor,
2000). Here, we have tested which DNMT isoforms are found in
developing olfactory progenitors and neurons, to establish how
they may regulate both embryonic and adult olfactory neuro-
genesis.Materials and methods
RT-PCR
OE tissue was microdissected from CD-1 mice of various developmental time points by peeling OE and lamina propria off the cartilaginous turbinates and
homogenizing in lysis buffer (Cowan et al., 2001) with a Fischer Sciences Powergen 125. RNAwas extracted from the homogenates using the Qiagen RNeasy kit.
First strand cDNAwas generated from 1.0 Ag of total RNA using the SuperScript II kit (Invitrogen). Negative control reactions were run with no reverse transcriptase
enzyme, and all primers were designed to span introns to also control for genomic DNA contamination. 1 Al of the first strand reaction was combined with 1 PCR
buffer (Invitrogen), 0.2 mM dNTPs, 3 mM MgCl2, 2.5 units Taq DNA polymerase (Invitrogen) and 1.25 mM primers. Primers were selected using the Primer3
program. The PCR cycling protocol was as follows; 94-C for 5 min (first cycle), followed by 94-C for 30 s, 58-C for 35 s, 72-C for 30 s (30 cycles), 72-C for 4 min
(last cycle) (using a PE Applied Biosystems Geneamp 9700). RT-PCR products were electrophoresed on a 1.5% TBE/agarose gel and the picture was captured using








Adult mice were anaesthetized with Xylaket (25% Ketamine HCL (MTC Pharmaceuticals), 2.5% Xylazine (Bayer Inc.), 15% ethanol, 0.55% NaCl) and rapidly
perfused with cold 0.1 M phosphate-buffered saline (PBS), followed by 4% paraformaldehyde (PFA) in PBS. Brains, olfactory bulbs and olfactory epithelia were
dissected out and post-fixed in 4% PFA for 2 h at 4-C. For embryos, mothers were anaesthetized and embryos dissected out and immersion-fixed in 4% PFA
overnight. All tissues were then equilibrated in 10% and 30% sucrose for 12–20 h each at 4-C, followed by warm Tissue-Tek embedding medium (Sakura Finetek,
Torrance, CA) for 5 min (under suction, except for embryos), and frozen in liquid nitrogen. 14 Am sequential coronal sections of adult OE and OB, sagittal sections
of whole embryos were prepared and stored at 20-C for subsequent analysis.
Immunohistochemistry
Was performed essentially as described previously (Au and Roskams, 2003), with modifications to maximize detection of nuclear transcripts. Sections were
permeabilized in 0.01 M citric acid, pH 6.0, for 10 min in the microwave on high power, followed by 0.1% Triton-X-100 in PBS for 30 min, blocked with 4% normal
serum in PBS for 20 min, and incubated at 4-C for 12–20 h with primary antibody in PBS. Primary antibodies used in this study were: mouse anti-DNMT1 (1:100
Imgenex), mouse anti-DNMT3b (1:100; Imgenex), mouse anti-DNMT3a (1:150; Imgenex), goat anti-Olfactory Marker Protein (1:5000; a gift from F.L. Margolis,
University of Maryland), mouse anti-neuron specific tubulin (hIII) (1:500; Babco), mouse anti-growth associated protein 43 (1:200; Chemicon), rabbit anti-neural
cell adhesion molecule (1:500; Chemicon), rabbit anti-HDAC2 (1:5000, Abcam), mouse anti-cytokeratin 5/6 (1:100; Boehringer Mannheim), mouse anti-PCNA
J.L. MacDonald et al. / Developmental Biology 288 (2005) 461–473 463(1:5000; Sigma) and diaminopyridine imidazole (DAPI; 1:10 000 for 5 min at room temperature, Sigma). For single antibody detection, we used biotin-conjugated
anti-mouse secondary antibodies, avidin–biotin–HRP complex kit, and the peroxidase substrate kit Vector VIP (all from Vector Laboratories, Burlingame, CA).
Sections were then dehydrated through a series of alcohols and xylene, and mounted with Permount (Fisher Scientific). For fluorescence detection, DNMT3b and
DNMT3a antibodies were detected with biotin conjugated anti-mouse secondary antibodies, avidin–biotin–HRP complex kit, and the Amplex Red substrate kit
(Molecular Probes) according to manufacturer’s instructions. All other primary antibodies were detected with fluorescently labelled secondary antibodies Alexa 488
and Alexa 594, raised in donkey (Molecular Probes).
Cell counts
A minimum of 3 animals per time point, E17 and P5, were used for cell counts. From each animal, 3 coronal sections were analyzed. In each section, 3 areas of
the olfactory epithelium were targeted for cell counts; the dorsal recess, along the septum just before the olfactory/respiratory epithelium boundary, and endo
turbinate IIb. A 200-Am stretch of olfactory epithelium was assayed.
Synchronization of OP27 cells in G1/S phase
OP27 cells were grown in DMEM/10% FBS at 33-C until they were 70–80% confluent. The cells were then switched to serum-free DMEM for 48 h after which
they were trypsinized and passaged into new TC flasks in DMEM/10% FBS and allowed to settle for 2 h. After 2 h, the media was supplemented with Aphidicolin (a
DNA synthesis inhibitor) to a final concentration of 0.25 Ag/ml and incubated for 12 h at 33-C.
Cell cycle analysis by fluorescence activated cell sorting
Between 300,000 and 500,000 OP27 cells were trypsinized and resuspended in PBS/2% FBS. The cells were centrifuged for 5 min and the pellet washed by
resuspension in PBS with 0.1 mg/ml RNAse and the sample incubated for 40 min in a 37-C water bath. 50 Ag/ml of propidium iodide was added and incubated for
10 min. The sample was then filtered and analyzed on a FACscalibur using CellQuest acquisition software. The acquired data files were then analyzed using the cell
cycle analyses platform in FlowJo 3.1. The best fit cell cycle composition was achieved using the 2-populations algorithm using a set G2 peak at 1.83XG1.
Immunocytochemistry
Immunocytochemistry protocols were essentially as described (Au and Roskams, 2003). Cells were grown on multi-chambered glass slides (Nunc, Rochester,
NY) coated with ECL (entactin–collagen IV– laminin) (Upstate). Cells were fixed with ice-cold methanol for 10 min and stored at 4-C in PBS with 0.05% azide
(Sigma) until staining. The cells were rinsed with PBS and permeabilized with 0.1% Tween-20, blocked in 4% normal donkey serum in PBS and incubated in
primary antibody (diluted in 2% serum) overnight. Immunofluorescent detection was performed as described above, and the slides were coverslipped with
Vectashield (Vector).
Image analysis
All images were visualized with an Axioplan 2 Imaging microscope (Zeiss, Jena GER) using a Retiga 1350EX camera (Quantitative Imaging Corporation) with
Northern Eclipse software (Empix Imaging Inc., Mississauga, ON) and were compiled using Adobe Photoshop 7.0.Results
Dnmt1, Dnmt2, Dnmt3a, and Dnmt3b are expressed in the
olfactory epithelium as early As E11 and persist into adulthood
To test which Dnmts are expressed in the mouse OE
during development, we performed reverse-transcription PCR
at embryonic day 11 (E11), E17, postnatal day 5 (P5) and
adult using intron-spanning primers. mRNA for Dnmt1,
Dnmt2, Dnmt3a and Dnmt3b were detected at all four time
points (Fig. 1A) with a larger transcript of Dnmt3a
occasionally detected at E11 (data not shown). Dnmt3b can
be alternatively spliced to produce functional variants that
affect the integrity of the catalytic domain (Okano et al.,
1998a; Robertson et al., 1999; Xie et al., 1999). The Dnmt3b
splice variants are primarily the result of two variable
regions, corresponding to the presence or absence of exons
11 and 22/23. The four mouse protein isoforms of DNMT3b
that are produced from alternate splicing are the full-length
DNMT3b1, DNMT3b2 which lacks exon 11, DNMT3b3
which contains neither exon 11 nor 22/23, and DNMT3b6
which lacks exons 22 and 23 (Chen et al., 2003). Primersflanking the alternatively spliced exon 11 (Fig. 1B),
produced a single 600 base pair product (Fig. 1C), indicating
that all Dnmt3b mRNAs expressed in the OE contain exon
11. In contrast, primers flanking the alternatively spliced
exons 22/23 identified two products, corresponding to 600
and 400 base pairs. This indicates that two splice variants of
Dnmt3b exist in the OE, one containing exons 22 and 23
and the other in which exons 22 and 23 are absent.
Therefore, Dnmt1, Dnmt2 and the de novo Dnmts 3a and
3b (including alternate isoforms Dnmt3b1 and Dnmt3b6) are
all expressed in the OE from early embryonic development
into adulthood.
DNMT1 is expressed at all stages of ORN neurogenesis
In addition to its role as a maintenance DNMT in cycling
cells, DNMT1 is highly expressed in post-mitotic neurons of
the brain (Brooks et al., 1996; Goto et al., 1994; Inano et
al., 2000). Because RT-PCR results indicated robust expres-
sion of Dnmt1 into adulthood in the OE, we wanted to
determine if DNMT1 is similarly expressed in mature
ORNs. Using double fluorescence immunohistochemistry
Fig. 1. Dnmts are expressed in the OE throughout development. cDNA
templates for PCR were generated by oligo-dT-primed reverse-transcription of
RNA harvested from the olfactory epithelium at E11, E17, P5, and adult (6
weeks). (A) PCR primers complementing the cDNA of maintenance
methyltransferase DNMT1, accessory methyltransferase DNMT2, and the de
novo methyltransferases DNMT3b and 3a amplified PCR products of
approximately 600 nt at all time points. (B) DNMT3b contains three coding
exons, 11 and 22/23, which are alternatively spliced (Alt Spl 1, Alt Spl 2). (C)
Primers spanning exon 11 (Alt. Spl 1) amplified a single 600 nt product from
all time points, corresponding to a DNMT3b cDNA template containing exon
11. Primers spanning exons 22/23 (Alt. Spl 2) amplify products of 600 nt and
400 nt at all time points, corresponding to two splice variants of DNMT3b, one
containing exons 22/23 and one without exons 22/23. h-actin was used as an
internal positive control for successful reverse transcription.
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ating cell nuclear antigen (PCNA) expressing cycling
progenitors (Fig. 2A) and is retained in post-mitotic cells
of the OE, where it is expressed in both growth-associated
protein 43 (GAP43) expressing immature neurons (Fig. 2B)
as well as olfactory marker protein (OMP) expressing
mature ORNs (Fig. 2C). DNMT1 also appears to be
expressed in a subpopulation of periaxonal olfactory
ensheathing cells within the lamina propria (Fig. 2), some
of which co-express PCNA (Fig. 2A).Fig. 2. DNMT1 is expressed at all stages of ORN neurogenesis. DNMT1 (red) is co
(arrows) as well as a subpopulation of cells located in the lamina propria (arrowhea
receptor neurons (arrow) and (C) OMP-positive (green) mature ORNs (arrow). DAPI
receptor neuron, ORN = olfactory receptor neuron. Scale bar = 50 Am.DNMT3b is expressed by presumptive globose basal cells in
the adult olfactory epithelium
Although the continuous expression of DNMT1 indicates
the need to maintain methylation marks in the development of
ORNs or mitotic olfactory ensheathing cell (OEC) precursors,
we do not know how these methylation marks may be
established. We tested if the de novo DNMTs 3a and 3b may
be developmentally regulated in ORN development where
methylation-dependent gene silencing could underscore shifts
in differentiation state. Using immunohistochemistry, we
found that DNMT3b is expressed within patches of cells
confined to a single cell layer of the adult OE, one cell layer
above the basal lamina (Fig. 3A). To further delineate the
identity of the DNMT3b expressing cells, we employed
double fluorescence immunohistochemistry using develop-
mentally-restricted ORN antigens (Fig. 3). DNMT3b is not
co-expressed with the mature ORN protein OMP (Fig. 3B),
with neural cell adhesion molecule (NCAM; Fig. 3C), or
cytokeratin 5/6, (Fig. 3D) a marker of horizontal basal cells
(HBCs) (Holbrook et al., 1995). The lack of co-detection of
HBC and neuronal markers suggests that DNMT3b-expres-
sing cells may be globose basal cells (GBCs), the neuronal
precursors of the OE. Unfortunately, we could not directly
colocalize DNMT3b with the GBC marker GBC-2 (Goldstein
and Schwob, 1996) as the GBC-2 antigen (unknown) was
sensitive to the antigen retrieval (citric acid) technique used to
detect DNMT3b.
The patchy distribution of DNMT3b in the adult OE
suggests that only a subpopulation of presumptive GBCs, the
most actively proliferating cells in the olfactory epithelium
(Schwartz Levey et al., 1991), express DNMT3b. To test if
DNMT3b is only expressed in mitotic (as opposed to
quiescent) precursors, we tested for co-expression of DNMT3b
with proliferating cell nuclear antigen (PCNA). PCNA is
synthesized during late G1 and early S-phases of the cell cycle,
immediately preceding the onset of DNA synthesis, and its
expression declines throughout G2 and mitosis, although it
may still be detected in some proliferating cells at G0 (Kurki et
al., 1986). Within the embryonic OE only, there are two distinct
subpopulations of dividing (PCNA-expressing) progenitors;
these are restricted to the most apical and most basal layers of
the OE. In the embryo, the majority of basally-situated PCNA--expressed with (A) PCNA (green) in the nuclei of basal cells of the adult OE
d). It is also detected in the cytoplasm of (B) GAP43-positive (green) immature
(blue) labels all nuclei. LP = lamina propria, BC = basal cells, IRN = immature
Fig. 3. DNMT3b is expressed in proliferating progenitors in the OE. (A)
DNMT3b (white) is not expressed continuously in the OE but in localized
patches. DNMT3b (red) is not co-expressed with (B) olfactory marker protein
(green), (C) neural cell adhesion molecule (green) or (D) cytokeratin 5/6
(green). DNMT3b (red) is co-expressed with PCNA (green) in the basal layers
of the OE at (E) E17, (F) P5, (G) 6 days after bulbectomy and (H) in the adult.
PCNA-positive (green) cells in the apical layers of the developing OE do not
co-express DNMT3b (arrowhead; E, F). PCNA-positive cells found in the
middle layers of the (E) E17 and (F) P5 OE co-express DNMT3b (arrow). (I, J)
DNMT3b-positive (red) cells in the middle layers of the OE do not co-express
NST (arrow), however, some of the basally located DNMT3b-positive cells do
co-express NST (arrowhead). ORN = olfactory receptor neuron, BC = basal
cells, NC = nasal cavity, PBx = 6 days post-bulbectomy. (A) Scale bar = 200
Am. (B–L) Scale bar = 50 Am.
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detected in the most apical PCNA-positive cells (Fig. 3E).
After embryonic development, mitosis and neurogenesis are
restricted to the basal progenitor population (Figs. 3F–H).Although the number of cycling, PCNA-expressing, cells
decreases as the OE matures, the majority of PCNA-expressing
progenitors continue to co-express DNMT3b (Figs. 3E, F, H).
This pattern of co-expression is recapitulated during bulbect-
omy-induced adult neurogenesis (Fig. 3G). During early
development, a small number of cells that co-express DNMT3b
and PCNA are found in the middle, immature ORN layers of
the developing OE (Figs. 3E, F). These DNMT3b-expressing
cells do not appear to co-express hIII neuron-specific tubulin
(NST), however, suggesting that they are part of a divergent
(non-neuronal) lineage (Figs. 3I, J). At E17 and P5, during
peaks of neurogenesis, rare cells expressing DNMT3b in
regions between the basal and immature neuronal layers do co-
express NST (Figs. 3I, J). These cells, however, display less
intense immunoreactivity for each antigen compared to cells
expressing DNMT3b or NST singly, suggesting that they may
be in transition from a dividing progenitor to a neuronal state.
Cells co-expressing DNMT3b and NST are rarely observed
during adult neurogenesis (Figs. 3K, L).
DNMT3b does not appear to be sequestered to replication foci
in an olfactory precursor line
DNMT3b thus appears to be expressed by olfactory
progenitors actively undergoing neurogenesis, and could be
laying down new methylation sites (after DNA replication) to
drive the progressive fate restriction of these progenitors or
maintaining methylation sites (at the replication fork) (Chen et
al., 2003). To exclude the possibility that DNMT3b is
maintaining methylation at the replication fork we tested for
its co-localization with PCNA (which is an integral component
of the replication fork) during the proliferation of olfactory
precursors in vitro. In the absence of a homogeneous
population of primary ORN progenitors in vitro, we employed
a conditionally immortalized embryonic ORN precursor clonal
cell line (OP27), derived from the olfactory placode (Illing et
al., 2002). After OP27 cells are moved to the non-permissive
temperature, they undergo one or two more rounds of division
before differentiating into ORNs and therefore likely represent
a GBC-like embryonic precursor. To enrich for cells in S-
phase, we first synchronized OP27 cells at the G1–S boundary
with aphidicolin, a chemical inhibitor of DNA synthesis
(Sheaff et al., 1991), then released them from inhibition. This
synchronization increased the percentage of cells at the G1–S
phase boundary, from 41% before synchronization to 73%, as
determined by FACS analysis (Figs. 4D–E). At G1, the nuclear
localization pattern of both PCNA and DNMT3b in OP27 cells
is diffuse and non-focal and does not overlap with the DNA
intercalating dye, DAPI. Two hours after release, 73% of cells
entered S-phase, as evidenced by an expansion in nuclear size
coupled with the shift of PCNA to a focal pattern (Figs. 4B–C)
characteristic of proteins clustered at the replication forks
(Nomura, 1994). As the cells progressed through S-phase,
DNMT3b and PCNA nuclear localization appeared more
divergent (Figs. 4B–C), most apparent at late S-phase where
large PCNA foci appeared devoid of co-localization with
DNMT3b. This suggests that DNMT3b is not recruited to
Fig. 4. DNMT3b is not sequestered to replication foci in olfactory precursors. Representative expression of PCNA (red), DNMT3b (green), and DAPI (blue) in the
nuclei of OP27 ORN precursor cells in (A) late G1 phase, (B) early S phase and (C) late S phase. (D) Typical cell cycle FACs profile of culture in G1 phase, (E)
enriched for early S-phase cells and (F) enriched for late S-phase cells.
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likely functioning as a de novo DNMT.
DNMT3a is induced in immature olfactory receptor neurons
RT-PCR analysis indicated that Dnmt3a is also expressed in
the OE throughout development (Fig. 1A). To determine if
DNMT3a and DNMT3b are expressed in the same or distinct
cell populations, we used immunohistochemistry to identify the
cells expressing DNMT3a in the adult OE. In comparison to
the patchy basal expression of DNMT3b, DNMT3a is more
uniformly distributed throughout the presumptive immature
neuronal layers of the OE (Fig. 5A). The DNMT3a-expressing
cells do not co-express cytokeratin 5/6 (Fig. 5B) or PCNA (Fig.
5C), indicating that DNMT3a is not detectably expressed in
dividing or quiescent basal progenitors, but is expressed in
most GAP43-expressing immature receptor neurons (IRNs)
(Fig. 5D).
hIII neuron specific tubulin (NST) begins to be expressed as
neuroblasts commit to neuronal differentiation and exit mitosis.
Maximal cell body expression of NST, therefore, is indicative
of a newly generated IRN (Illing et al., 2002; Roskams et al.,
1998). The majority of NST-expressing IRNs co-express
DNMT3a both developmentally (Figs. 5E, F), and in the adult
(Figs. 5G, H) but at E17 and P5 a small subset of basally-
located NST-expressing IRNs (similar to the frequency found
co-expressing DNMT3b) do not detectably express DNMT3a
(Figs. 5E, F). During development, a more mature subpopu-
lation of DNMT3a-expressing ORNs begin to express OMP
(Figs. 5I, J), but this is more rare in the adult OE (Figs. 5K, L).
Bulbectomy-induced neurogenesis elicits an expansion of
DNMT3a-expressing IRNs, (Figs. 5 G, K), where DNMT3a
is largely co-expressed by NST-expressing (Fig. 5G), OMP-
negative IRNs (Fig. 5K). The number of DNMT3a-expressing
IRNs in all regions of the OE increases from 37.3 T 3.2 per 100
Am of linear OE at E17 to 63.5 T 5.3 per 100 Am at P5,
concomitant with the increase in the number of ORNs
undergoing neuronal differentiation during this period.Histone deacetylase 2 expression is induced in post-mitotic
ORNs, but is lost as they terminally differentiate
To determine if the methylation patterns established by
either DNMT3b or 3a may be associated with changes in
chromatin structure during olfactory neurogenesis we exam-
ined the expression pattern of histone deacetylase 2 (HDAC2).
HDAC2 was identified in an earlier suppression subtraction
screen performed in our lab (that had also identified DNMT3b)
for genes up-regulated at the peak of ORN neurogenesis. In the
embryonic OE, HDAC2 is first expressed by a small
subpopulation of basal PCNA-expressing progenitors (Figs.
6A, B). HDAC2 is similarly co-expressed with DNMT3b in a
small subpopulation of mitotic basal progenitors throughout
development and into adulthood (Figs. 6D–F). Expression of
HDAC2 extends into the neuronal layers of the OE, where the
more apical HDAC2 expressing neurons overlap with the more
basal DNMT3a expressing neurons (Figs. 6G–I). Rare
examples of co-expression of HDAC2 and OMP are found in
the more basally situated mature ORNs (Fig. 6C).
Histone deacetylases 1 and 2 are expressed at distinct stages of
ORN development
Because expression of HDAC2 is largely restricted to the
immature ORN population, we wished to determine if alternate
HDACs might be associated with repressor complexes at
different points of ORN development. We found that, despite
their commonly reported association in MBD-mediated co-
repressor complexes, HDAC1 and HDAC2 display divergent
expression patterns within developing ORNs. HDAC1 is
highly expressed within PCNA-positive, NST-negative, cycling
basal cell progenitors (Figs. 7A, B) and occasionally co-
expressed with PCNA in the middle and apical layers of the OE
(Fig. 7A). HDAC1 is also co-expressed in non-cycling OMP-
positive mature ORNs (Fig. 7C), as well as in NST/OMP-
negative Sustentacular cells located apically to ORNs.
HDAC2, on the other hand, is largely co-expressed in NST-
Fig. 5. DNMT3a is dynamically expressed in the nuclei of post-mitotic neurons
in the OE. (A) DNMT3a (white) is generally expressed in a continuous layer in
the adult OE. DNMT3a (red) is not co-expressed with (B) cytokeratin 5/6
(green) in HBCs, (C) or with PCNA (green) in GBCs. (D) The majority of
DNMT3a-positive cells co-express the immature neuronal marker GAP43, but
most mature DNMT3a-positive cells do not express GAP43 (arrowhead). (E–
H) DNMT3a (red) is co-expressed with NST (green) throughout the
development of the OE. In the P5 OE (F), a population of NST-positive/
DNMT3a-negative cells (arrowhead) is found basally to the DNMT3a
expressing cells. In the (G) post-bulbectomy (H) adult tissues, the majority
of NST-positive cells co-express NST. At (I) E17 and (J) P5, the majority of
OMP-positive cells co-express DNMT3a. In (L), the normal adult OE and (K)
following bulbectomy, only a subset of the more basally situated OMP-positive
cells co-express DNMT3a. White dashed line = basal lamina, NC = nasal
cavity, T = turbinate, PBx = 6 days post-bulbectomy. (A) scale bar = 200 Am,
(B–L) Scale bar = 50 Am.
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PCNA+ cycling progenitors (Fig. 7E) or OMP+ mature ORNs
(Fig. 7G), The majority of DNMT3b expressing progenitors
co-express HDAC1 (Fig. 7D), while only a few co-express
HDAC2 (Fig. 7H).
Stage-specific expression of DNMT3b and DNMT3a in other
regions of the developing nervous system suggest conserved
mechanisms of action for DNMTs in nervous system
development
The previous data suggest dynamic shifts in expression of
interacting DNA methylation and chromatin condensing
factors in ORN development. We tested if these patterns were
restricted only to the ORN lineage, or may be present in other
sensory or CNS neurons (Fig. 8). The epithelium of the
vomeronasal organ (VNOE), the pheromone sensing organ, is
organized in a similar developmentally hierarchical manner
with progenitors located near the basal lamina and mature
receptor neurons (VNRNs) in the apical layers (Halpern and
Martinez-Marcos, 2003). The expression pattern of DNMT3b
and DNMT3a in the VNOE closely resembles that seen in the
OE. In the P5 VNOE, DNMT3b is co-expressed in PCNA-
expressing progenitors near the basal lamina (Fig. 8A).
DNMT3a, on the other hand, is only detected in cells in
neuronal layers (Fig. 8B). DNMT3b and 3a are expressed in a
similar mutually exclusive pattern during development of the
embryonic retina (shown at E17), where DNMT3b is expressed
in the outer neuronal layer when it is rich in mitotic
progenitors, and DNMT3a is found in the more differentiated
neuronal (NST+) ganglion cell layer, and the retinal pigment
epithelium (Figs. 8C, D). DNMT3b is similarly found in
developing taste buds at E17 (Fig. 8E) (Wong et al., 1994),
where it is found in basally-situated progenitors co-expressed
with PCNA at the base of the taste bud pit (Fig. 8E). In the
CNS portion of the olfactory system, expression of the de novo
DNMTs is once again at mutually exclusive stages of
development, where DNMT3a (not 3b) is detected concomi-
tantly with PCNA in the more primitive progenitors where they
are dividing along the ventricular walls as well as in neurons
undergoing differentiation in the cortex and mitral cell layer of
the olfactory bulb (Fig. 8G). DNMT3b is not detected in
ventricular progenitors or differentiated (NST+) neurons, but is
expressed in migratory neuroblasts (Fig. 8F).
Discussion
To begin to understand how DNA methylation may
influence the differentiation of a single neuronal lineage, we
have shown that DNMTs and their downstream effectors,
HDACs, are expressed in a highly dynamic, sequential, stage-
specific manner during ORN differentiation. The maintenance
methyltransferase, DNMT1, is expressed at all post-stem cell
stages of ORN development, and is also detected in
developing olfactory ensheathing cells (OECs). In contrast,
the detection of DNMT3b expression is restricted to
proliferating, neurogenic progenitors, and DNMT3a is
Fig. 6. Histone deacetylase 2 expression is induced after DNMT3b. (A, B) HDAC2 is co-expressed by a small subpopulation of PCNA-positive cells in both the
basal (arrowhead) and middle (thin arrow) layers of the E17 (A) and P5 OE (B). (D–F) HDAC2 is co-expressed in a subpopulation of basally situated DNMT3b-
positive cells (arrowhead) in the E17 (D), P5 (E) and adult (F) OE, however, many DNMT3b-positive cells do not co-express HDAC2 (arrow). (G– I) HDAC2 is co-
expressed in many DNMT3a-positive cells in the OE. At E17 (G) and P5 (H), the most apical cells express DNMT3a exclusively (arrow) and the most basal cells
express HDAC2 exclusively (arrowhead). In the adult OE (I), the apical DNMT3a-positive/HDAC2-negative population is no longer apparent. (C) HDAC2 is co-
expressed in only a small subpopulation of OMP-positive cells (arrowhead) in the adult. Scale bars = 50 Am.
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maturity and synaptic stabilization. HDAC1 expression
coincides with DNMT3b in the cycling progenitors and is
reinitiated in mature ORNs, before the termination of
DNMT3a expression. HDAC2 expression is induced in a
subset of DNMT3b expressing progenitors, and is maintained
throughout the immature ORNs. This suggests that HDACs
are capable of responding to the methylation marks laid downFig. 7. Histone deacetylases 1 and 2 are differentially expressed in the postnatal OE.
layers of the post-natal OE with most of the PCNA-positive progenitors in all layer
basal and apical HDAC1-expressing cells do not co-express NST (arrows), howev
Similar to PCNA, most DNMT3b-positive cells also co-express HDAC1 (arrowh
arrowhead), with (F) most HDAC2 expression coinciding with NST and (G) in some
in a subset of DNMT3b-positive cells (arrowhead). Scale bars = 50 Am.by both of these DNMTs. This has lead us to propose a
model whereby ORNs (and other neurons) undergo check-
points in development where genes no longer needed for
future development are silenced epigenetically, to allow for
increased cellular specialization as a neuron differentiates
(summarized in Fig. 9). This sequential induction of
epigenetic modifiers during commitment and differentiation
appears to be common to different neuronal lineages.(A) HDAC1 (green) is highly expressed in both the apical (arrow) and basal cell
s of the OE co-expressing HDAC1 (arrowheads). (B) The majority of the most
er (C) many OMP-positive neurons do co-express HDAC1 (arrowhead). (D)
ead). (E) Only a subset of PCNA-positive cells co-express HDAC2 (green;
cases OMP (arrowhead). In a similar frequency to PCNA, HDAC2 is expressed
Fig. 8. The sequential expression pattern of DNMT3b and DNMT3a is
paralleled in other chemosensory systems. (A) DNMT3b (red) is expressed in
nuclei in the developing, P5, vomeronasal organ where it is co-expressed with
PCNA (green) in the vomeronasal epithelium (arrow), but not in the respiratory
epithelium (arrowhead). (B) DNMT3a (red) is not co-expressed with PCNA
(green, arrow) in the P5 vomeronasal organ but is expressed in the more apical
cell layers. (C) DNMT3b is expressed in a subpopulation of cells in outer nerve
layer (ONL) of the E17 retina (arrow), but is not expressed in the nuclei of NST
expressing neurons (green). (D) DNMT3a is expressed in the retinal pigment
epithelium (RPE) cells of the E17 retina (arrowhead) as well as a subpopulation
of NST (green) expressing neurons in the granule cell layer (GCL, arrow). (E)
DNMT3b is also expressed in the developing taste buds of the P5 tongue,
where it is co-expressed with PCNA (arrowhead). (F) DNMT3b is expressed in
a subset of cells throughout the developing, E17 brain cortex (arrows) and
rostral migratory stream (arrowhead). Inset = 4 magnification of white box.
(G) DNMT3a is co-expressed with PCNA in the lateral ventricle (LV) and
olfactory bulb (OB) at E17 (arrows) and is also expressed in PCNA-negative
cells within the developing cortex and OB (arrowheads). PCNA-positive cells
in other regions of the brain do no co-express DNMT3a (*) VNRN =
vomeronasal receptor neurons, RE = respiratory epithelium. (A–E) Scale bar =
100 Am, (F, G) Scale bar = 400 Am.
Fig. 9. Summary of DNMT expression in the OE. DNMT3b is expressed in
proliferating progenitors, as they are transitioning to an immature neuronal
state. Expression of DNMT3a is induced in post-mitotic neurons, coinciding
with the transition from an immature receptor neuron to a mature phenotype.
HDAC2, an effector of DNA methylation, is expressed during both transitional
stages. DNMT1 is expressed in proliferating progenitors as well as in the
cytoplasm of all post-mitotic neurons. Potential checkpoints of ORN
development that may be mediated by methylation-dependent repressive
mechanisms are indicated (arrowheads 1, 2, 3).
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the developing OE from its early formation at E11 through
adulthood (Fig. 1). DNMT1, which functions largely in the
maintenance of DNA methylation, is expressed both in the
cycling progenitors and in the ORNs of all developmental
stages (Fig. 2), consistent with a role in supporting ongoing
development and maintaining established methylation marks in
developing ORNS and OECs throughout adult neurogenesis
(Carr and Farbman, 1992; Graziadei and Graziadei, 1979;
Huard et al., 1998). Although Dnmt2 expression was also
detected, the catalytic function of this methyltransferase is stillin question (Hermann et al., 2003; Okano et al., 1998b), and its
potential role in ORN genesis was therefore not pursued
further. The expression of DNMT1 in the mitotic olfactory
progenitor population is not surprising because it directly
associates with the replication fork, conserving the methylation
pattern on the daughter strand during DNA replication
(Pradhan et al., 1999; Yoder et al., 1997). Cytoplasmic
localization of DNMT1 in ORNs is unusual, but has been
reported in other post-mitotic neurons of the CNS, and the
oocyte (Brooks et al., 1996; Goto et al., 1994; Inano et al.,
2000).
Detection of both de novo Dnmt3a and 3b in the OE into
adulthood is much more intriguing in the context of
developmental gene regulation, as the primary action of these
DNMTs was previously thought to be restricted to early
embryonic development (Okano et al., 1998a). Dnmt3b can
be expressed as alternate splice variants that directly affect the
integrity of the catalytic domain (Okano et al., 1998a;
Robertson et al., 1999). Variants excluding exons 22 and 23
(Fig. 1) lack the conserved functional motifs VII, VIII, the
transcriptional repression domain (TRD), and nine amino
acids of motif IX (Robertson et al., 1999). Variants in which
exon 11 is excluded (Alt. Splice 1, Fig. 1), however, still
contain all of the conserved motifs as well as the TRD
(Okano et al., 1998a; Xie et al., 1999). All Dnmt3b transcripts
in the OE contained exon 11, but only a subset contained
exons 22 and 23 (Fig. 1), corresponding to protein isoforms
DNMT3b1 and DNMT3b6 (Chen et al., 2003). Therefore, the
Dnmt3b transcripts detected represent fully active DNMT3b
(3b1), in addition to potentially dominant-negative forms
(3b6). Interestingly, exon 11 was previously thought exclusive
to embryonic stem cells, whereas Dnmt3b transcripts from
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suggests ORN progenitors may utilize DNA methylation-
dependent gene silencing mechanisms that are highly con-
served from early embryonic development.
During embryonic development, the OE contains two
distinct progenitor subpopulations—at the apical and basal
interfaces. From E17 to P5 to adulthood, OE progenitor activity
shifts from a primarily apical to a basally-situated location
(Caggiano et al., 1994; Smart, 1971), at which point DNMT3b
expression is restricted to a subpopulation of actively cycling
basal GBC precursors (Fig. 3). These DNMT3b-expressing
mitotic progenitors expand rapidly following bulbectomy-
induced adult neurogenesis, implicating DNMT3b in regulat-
ing the fate of adult presumptive GBCs that are responding to
neurogenic stimuli. Similarly, at E17, although both apical and
basal progenitors are actively dividing, DNMT3b is only
detected with PCNA in basal progenitors, with a small
subpopulation of PCNA+/ DNMT3b+/NST-negative cells
within the middle layers of the OE (Fig. 3). During later
stages of development, these cells may be migrating from the
apical progenitor layer to the basal layers or they may be GBC-
derived progeny that are migrating to form sustentacular cells
(Chen et al., 2004). The dynamic shifts of DNMT3b-expres-
sing mitotic progenitors revealed a developmental gradient,
where the relocation of DNMT3b-expressing progenitors to the
basal compartment was complete by E17 in the septum, but not
complete in the major endoturbinates until P5 and the dorsal
recess until a month postnatal (data not shown). This suggests
that a gradient of regional ORN generation exists within
different embryonic time windows, and may indicate time
windows for axogenesis related to regional CNS targeting,
similar to that seen for other peripheral sensory structures.
The co-expression of DNMT3b and PCNA within the OE
(Fig. 3) leaves open the possibility that DNMT3b could also
function in a more restricted role in maintenance methylation
during mitosis (Chen et al., 2003; Okano et al., 1998a). In this
context, it should co-localize with PCNA at the replication fork
during the peak of DNA synthesis (S-phase) in mitotic
olfactory precursors, however this is not detected (Fig. 4).
Therefore, DNMT3b is likely only acting after DNA synthesis
to establish new methylation marks in progenitors of the
olfactory system preparing to differentiate, consistent with the
role of DMNT3b and 3a in embryonic mouse myoblast cells
(Margot et al., 2001). As such, DNMT3b may initiate gene
silencing to (1) prevent re-entry to the cell cycle, (2) prevent a
choice of alternative (glial or neuronal) lineages or (3) exclude
expression of entire clusters of odorant receptors.
In stark contrast to DNMT3b, DNMT3a is detected
exclusively in immature post-mitotic ORNs (Fig. 5). DNMT3a
expression is most coincident with GAP-43 or NST in
immature ORNs (IRNs) but is detected in some OMP-
expressing ORNs during peaks of neurogenesis in development
or following lesion (Fig. 5). Similarly, at the beginning of ORN
differentiation, a basal subpopulation of NST-expressing IRNs,
directly adjacent to mitotic progenitors, do not yet detectably
co-express DNMT3a. As such, DNMT3a is likely induced in
post-mitotic IRNs after olfactory precursors have committed toa neuronal lineage, and is coincident with the onset of
expression of odorant receptors (ORs) (Iwema et al., 2004).
Because DNMT3a expression is progressively down-regulated
as ORNs functionally mature, it may be laying down
methylation marks essential for transitioning IRNs from a
developing state into one of terminal ORN differentiation.
Here, it may silence genes that were needed for IRN
differentiation (e.g., axon guidance genes), but that are no
longer required as ORNs complete targeting and solidify their
synaptic fate, thus inducing OMP. Perhaps most intriguingly,
DNMT3a expression is induced when an ORN is progressively
restricting its choice to one or a few clustered ORs, from a
potential pool of over 1,000. That ORs, like imprinted genes,
are tightly clustered and odorant preferences are behaviorally
trait-linked to maternal and paternal lineages, make ORs an
attractive candidate for epigenetic regulation by methylation-
dependent chromatin condensation (Isles et al., 2001).
DNA methylation mediates gene silencing largely through
the recruitment of chromatin condensing repressor complexes,
containing HDACs (Bird, 2002; Li, 2002). Expression of
HDAC2 in the OE is induced intermediately to DNMT3b and
3a, overlapping with a subpopulation of DMNT3b expressing
basal cells and DNMT3a-expressing ORNs (Fig. 6). Surpris-
ingly, HDAC1 is not expressed at the same developmental
stages in the OE as HDAC2 with the two appearing instead to
alternate expression (Fig. 7). HDAC1 is expressed in the
majority of cycling progenitors, is down-regulated in the
immature ORNs (which then express HDAC2), and then
reinduced in the mature ORNs (which down-regulate HDAC2).
As such, HDAC1 and HDAC2 may provide specificity to co-
repressor complexes distinct to different transitional stages of
ORN development. Although HDACs could directly interact
with DNMTs in the OE (Li, 2002), it is highly likely that they
are recruited by MBD-containing complexes. Other silencing
complex members such as Sin3a, Sir2a are also developmen-
tally regulated in IRNs (Roskams lab, unpublished observa-
tions) (Yu et al., 2005). The expression of MBD2 and 3 are
similarly restricted to early and late developmental time
windows in OE development (Jung et al., 2003) (MacDonald
et al, in preparation), and MeCP2 in particular has been
functionally implicated in regulating terminal ORN maturation
(Cohen et al., 2003).
The sequential expression of de novo DNMTs 3a and 3b is
not exclusive to the ORN lineage and appears to be conserved
in other developing chemosensory systems, such as the
vomeronasal organ (VNO), retina and taste buds and the
CNS (Fig. 8). In the VNO, taste bud and retina, DNMT3b is
found in more primitive mitotic progenitors, whereas DNMT3a
is expressed in more highly differentiated post-mitotic neurons.
In the developing CNS, DNMT3a is found both early (in
mitotic ventricular progenitors) and late (in differentiating
olfactory bulb and cortical neurons) in development, whereas
DNMT3b is intermediate, in migrating neuroblasts of the
rostral migratory stream (RMS) and cortex. The sequential
usage of de novo methyltransferases in nervous system
development seen in ORNs is supported by the limited data
available from null mice for DNMT3a and 3b. DNMT3b mice
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beginning to develop. In contrast, the DNMT3a null survives
embryonic development, but dies within a month of birth,
coincident with a defect in terminal neuronal maturation
(Okano et al., 1999), a phenotype already implicated in the
MeCP2 mutant phenotype (Guy et al., 2001; Kishi and
Macklis, 2004; Shahbazian et al., 2002).
The consecutive requirement for different DNMTs at stem
cell, mitotic progenitor and differentiating neuronal states
suggest that epigenetic mechanisms underlie shifts in plasti-
city in different nervous system lineages. Thus, ORNs, (rather
than being solely dependent on transcriptional activation to
differentiate), may possess checkpoints of stage-specific
development that require the silencing of genes no longer
required in future development, prior to entering the next
differentiation stage (indicated on Fig. 9). Checkpoint 1
occurs when quiescent stem cells shift into mitosis and is
marked by the onset of cell cycle entry (PCNA, Ki67,
phospho-Histone H3, H2 expression), is coincident with
DNMT3b induction, and accompanied by the down-regula-
tion of genes (e.g., integrins, cadherins, EGFR) required for
maintaining quiescence (Carter et al., 2004). Checkpoint 2
occurs as dividing progenitors exit mitosis and commit to a
neuronal lineage. In ORNs, this would be stimulated by
DNMT3b, mediated by MBD2/HDAC2, and accompanied by
the silencing of genes that regulate cell cycle and DNA
synthesis (e.g., PCNA, cyclins). Alternatively, as OECs
derived from OE-based progenitors do not express DNMT3b,
it could potentially silence genes whose regulation is known
to be methylation-sensitive (e.g., GFAP, S100h) that would
preferentially allow differentiation of progenitors into non-
ORN (glial) lineages (Namihira et al., 2004; Song and Ghosh,
2004; Takizawa et al., 2001). Checkpoint 3 occurs as IRNs
lose developmental plasticity and transition into a mature,
reinforced stable state (stimulated by DNMT3a, regulated, at
least in part, by MeCP2) (Cohen et al., 2003). This stage is
accompanied by the silencing of genes (e.g., BDNF, GAP43,
neuronal NOS) that mediate outgrowth and maintain plasticity
in ORN targeting (Margolis et al., 1991; Roskams et al.,
1994), but whose continued expression could destabilize
terminal neuronal differentiation. Perhaps the most intriguing
possibility is that ORNs might have evolved a specialized
mechanism whereby they could mobilize DNMT3b and 3a to
sequentially control the epigenetic silencing of ORs or their
unselected allele, and permit the development of a more
unique, sensitive olfactory repertoire over the lifespan of a
single ORN (Chess et al., 1994). This is the first study to
suggest that these highly critical shifts in state of developing
neurons may be driven largely by epigenetic changes that are
induced by stage-specific methylation marks laid down by de
novo DNMT3a and 3b.
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